Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medicines Company (MDCO)

Medicines Company (MDCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,768,482
  • Shares Outstanding, K 79,723
  • Annual Sales, $ 6,140 K
  • Annual Income, $ -123,160 K
  • 60-Month Beta 1.10
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.98
  • Most Recent Earnings -0.72 on 10/30/19
  • Next Earnings Date 02/26/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.90
  • Number of Estimates 6
  • High Estimate -0.74
  • Low Estimate -1.19
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -34.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.88 +1.22%
on 12/05/19
84.98 -0.09%
on 01/03/20
+0.80 (+0.95%)
since 12/03/19
3-Month
48.96 +73.41%
on 10/04/19
84.98 -0.09%
on 01/03/20
+34.87 (+69.70%)
since 10/03/19
52-Week
17.81 +376.70%
on 01/04/19
84.98 -0.09%
on 01/03/20
+67.04 (+375.36%)
since 01/03/19

Most Recent Stories

More News
Uptrend Call Working As Medicines Comp Stock Rises 19.9% (MDCO)

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 3 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

MDCO : 84.90 (-0.07%)
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

Style Box ETF report for FNY

FNY : 51.08 (+0.10%)
IWP : 162.18 (+0.42%)
MDCO : 84.90 (-0.07%)
ARWR : 41.27 (+0.54%)
CVNA : 88.62 (+1.40%)
IJK : 246.56 (+0.02%)
Medicines Comp Up 19.9% Since SmarTrend Uptrend Call (MDCO)

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 3 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

MDCO : 84.90 (-0.07%)
Uptrend Call Working As Medicines Comp Stock Rises 19.9% (MDCO)

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 2 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

MDCO : 84.90 (-0.07%)
Uptrend Call Working As Medicines Comp Stock Rises 19.9% (MDCO)

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on November 19th, 2019 at $70.84. In approximately 2 months, Medicines Comp has returned 19.86% as of today's recent price of $84.90.

MDCO : 84.90 (-0.07%)
The Medicines Company Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022, 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 2024

The Medicines Company (the "Company") today provided notice of a Make-Whole Fundamental Change to holders of its (i) 2.50% Convertible Senior Notes due 2022 (the "2022 Notes"), (ii) 2.75% Convertible Senior...

NVS : 97.63 (-0.14%)
MDCO : 84.90 (-0.07%)
Novartis completes tender offer for all outstanding shares of The Medicines Company

Basel, January 6, 2020 -- Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender offer by its indirect wholly-owned subsidiary, Medusa Merger...

NVS : 97.63 (-0.14%)
MDCO : 84.90 (-0.07%)
3 Biotech Stocks Likely to Maintain Solid Momentum in 2020

With the biotech sector gaining steam in recent times, we shortlist three biotech stocks that are set to maintain momentum in 2020.

NVS : 97.63 (-0.14%)
BMY : 66.38 (+0.45%)
ALXN : 102.56 (-0.83%)
CLLS : 17.47 (+0.06%)
MDCO : 84.90 (-0.07%)
AMRN : 17.62 (-0.40%)
Relatively Good Performance Detected in Shares of Dermira in the Pharmaceuticals Industry (DERM , MDCO , BMY , MRK , ZTS )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

BMY : 66.38 (+0.45%)
DERM : 18.74 (unch)
MDCO : 84.90 (-0.07%)
NexPoint Residential Trust and Meritor Set to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the open of trading on Monday, January 6:

NXRT : 52.00 (+1.54%)
AVP : 5.60 (-0.88%)
MTOR : 25.60 (unch)
MDCO : 84.90 (-0.07%)
SPGI : 307.65 (+2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade MDCO with:

Business Summary

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare...

See More

Key Turning Points

2nd Resistance Point 85.02
1st Resistance Point 84.96
Last Price 84.90
1st Support Level 84.86
2nd Support Level 84.82

See More

52-Week High 84.98
Last Price 84.90
Fibonacci 61.8% 59.32
Fibonacci 50% 51.40
Fibonacci 38.2% 43.47
52-Week Low 17.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar